Lawrence Steinman 180 Life Sciences Corp. (ATNF) insider trading activity

Lawrence Steinman is Director of 180 Life Sciences Corp.. Currently has a direct ownership of 67,534 shares of ATNF, which is worth approximately $87,794. The most recent transaction as insider was on Feb 20, 2025, when has been sold 65,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.5K

40.32% 3M change

40.32% 12M change

Total Value Held $87,794

LAWRENCE STEINMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2025	BUY Grant, award, or other acquisition	-	65,000 Added 49.04%	67,534 Common Stock
Jun 01 2023	BUY Open market or private purchase	$22,140 $1.23 p/Share	18,000 Added 27.22%	48,129 Common Stock
Dec 09 2021	BUY Open market or private purchase	$21,350 $4.27 p/Share	5,000 Added 0.82%	602,574 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	$31,296 $6.0 p/Share	5,216 Added 0.87%	597,574 Common Stock
Apr 07 2021	BUY Grant, award, or other acquisition	$138,672 $6.14 p/Share	22,585 Added 3.67%	592,358 Common Stock

Also insider at

BCAB

BioAtla, Inc. Healthcare

KTTA

Pasithea Therapeutics Corp. Healthcare

Director